A further genetic abnormality associated with an enhanced risk for CNS infiltration is the t(9;22)(q34;q11.2) translocation leading to the BCR-ABL fusion gene (Philadelphia chromosome positive BCP-ALL). This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.